technetium tc 99m dimercaptosuccinic acid has been researched along with MEA 2a in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cascone, E; Celentano, L; Klain, M; Lupoli, G; Salvatore, M; Sullo, P | 1 |
1 other study(ies) available for technetium tc 99m dimercaptosuccinic acid and MEA 2a
Article | Year |
---|---|
111In-pentetreotide scintigraphy in the post-thyroidectomy follow-up of patients with medullary thyroid carcinoma.
Topics: Adult; Aged; Calcitonin; Carcinoembryonic Antigen; Carcinoma, Medullary; Diagnostic Imaging; Female; Follow-Up Studies; Humans; Indium Radioisotopes; Iodine Radioisotopes; Lymphatic Metastasis; Male; Middle Aged; Multiple Endocrine Neoplasia Type 2a; Neoplasm Recurrence, Local; Organotechnetium Compounds; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Somatostatin; Succimer; Survival Rate; Technetium Tc 99m Dimercaptosuccinic Acid; Thyroid Neoplasms; Thyroidectomy | 1995 |